| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.44 | 0.004 |